Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from China Traditional Chinese Medicine Holdings Co ( (HK:0570) ).
China Traditional Chinese Medicine Holdings Co. Limited has appointed Mr. Peng Li as an executive director and a member of the strategic committee, effective July 25, 2025. Mr. Peng brings extensive experience in traditional Chinese medicine and leadership roles within the healthcare sector, which is expected to bolster the company’s strategic direction and operational expertise.
The most recent analyst rating on (HK:0570) stock is a Buy with a HK$5.00 price target. To see the full list of analyst forecasts on China Traditional Chinese Medicine Holdings Co stock, see the HK:0570 Stock Forecast page.
More about China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited operates in the traditional Chinese medicine industry, focusing on the development and distribution of traditional Chinese medicinal products. The company is part of the China National Pharmaceutical Group and aims to enhance its market position through strategic appointments and innovations in the field.
Average Trading Volume: 23,301,564
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.83B
Learn more about 0570 stock on TipRanks’ Stock Analysis page.